Evercore ISI Group Downgrades Bio-Techne to In-Line, Lowers Price Target to $62

Benzinga · 5d ago
Evercore ISI Group analyst Daniel Markowitz downgrades Bio-Techne (NASDAQ:TECH) from Outperform to In-Line and lowers the price target from $68 to $62.